[1]
Brogden RN,Carmine A,Heel RC,Morley PA,Speight TM,Avery GS, Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use. Drugs. 1981 Nov;
[PubMed PMID: 7037354]
[2]
Benninger MS, Amoxicillin/clavulanate potassium extended release tablets: a new antimicrobial for the treatment of acute bacterial sinusitis and community-acquired pneumonia. Expert opinion on pharmacotherapy. 2003 Oct;
[PubMed PMID: 14521493]
Level 3 (low-level) evidence
[3]
Bucher HC,Tschudi P,Young J,Périat P,Welge-Lüussen A,Züst H,Schindler C, Effect of amoxicillin-clavulanate in clinically diagnosed acute rhinosinusitis: a placebo-controlled, double-blind, randomized trial in general practice. Archives of internal medicine. 2003 Aug 11-25;
[PubMed PMID: 12912714]
Level 1 (high-level) evidence
[4]
Jacobs MR, Extended release amoxicillin/clavulanate: optimizing a product for respiratory infections based on pharmacodynamic principles. Expert review of anti-infective therapy. 2005 Jun;
[PubMed PMID: 15954852]
[5]
White AR,Kaye C,Poupard J,Pypstra R,Woodnutt G,Wynne B, Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent. The Journal of antimicrobial chemotherapy. 2004 Jan;
[PubMed PMID: 14726431]
[6]
Iravani A,Richard GA, Treatment of urinary tract infections with a combination of amoxicillin and clavulanic acid. Antimicrobial agents and chemotherapy. 1982 Oct;
[PubMed PMID: 7181477]
[7]
Fleisher GR,Wilmott CM,Campos JM, Amoxicillin combined with clavulanic acid for the treatment of soft tissue infections in children. Antimicrobial agents and chemotherapy. 1983 Nov;
[PubMed PMID: 6660847]
[8]
Marchant CD,Shurin PA,Johnson CE,Murdell-Panek D,Feinstein JC,Fulton D,Flexon P,Carlin SA,Van Hare GF, A randomized controlled trial of amoxicillin plus clavulanate compared with cefaclor for treatment of acute otitis media. The Journal of pediatrics. 1986 Nov;
[PubMed PMID: 3534203]
Level 1 (high-level) evidence
[9]
Abrahamian FM, Dog Bites: Bacteriology, Management, and Prevention. Current infectious disease reports. 2000 Oct;
[PubMed PMID: 11095891]
[10]
Antimicrobial prophylaxis in surgery. The Medical letter on drugs and therapeutics. 2001 Oct 29;
[PubMed PMID: 11689761]
Level 3 (low-level) evidence
[11]
Dajani A,Taubert K,Ferrieri P,Peter G,Shulman S, Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Pediatrics. 1995 Oct;
[PubMed PMID: 7567345]
[12]
Stein GE,Gurwith MJ, Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination. Clinical pharmacy. 1984 Nov-Dec;
[PubMed PMID: 6391783]
[13]
Wise R,Andrews JM,Bedford KA, In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin. Antimicrobial agents and chemotherapy. 1978 Mar;
[PubMed PMID: 122520]
[14]
Bax R, Development of a twice daily dosing regimen of amoxicillin/clavulanate. International journal of antimicrobial agents. 2007 Dec;
[PubMed PMID: 17983732]
[16]
Björnsson ES, Hepatotoxicity by Drugs: The Most Common Implicated Agents. International journal of molecular sciences. 2016 Feb 6
[PubMed PMID: 26861310]
[17]
Evans CM,Purohit S,Colbert JW,Lear PA,Makin T,Scobie DJ,Williamson EP,Sells RA, Amoxycillin-clavulanic acid (Augmentin) antibiotic prophylaxis against wound infections in renal failure patients. The Journal of antimicrobial chemotherapy. 1988 Sep;
[PubMed PMID: 3053562]
[19]
Thompson DF,Ramos CL, Antibiotic-Induced Rash in Patients With Infectious Mononucleosis. The Annals of pharmacotherapy. 2017 Feb;
[PubMed PMID: 27620494]
[20]
Ónodi-Nagy K,Kinyó Á,Meszes A,Garaczi E,Kemény L,Bata-Csörgő Z, Amoxicillin rash in patients with infectious mononucleosis: evidence of true drug sensitization. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology. 2015;
[PubMed PMID: 25784943]
[22]
deLemos AS,Ghabril M,Rockey DC,Gu J,Barnhart HX,Fontana RJ,Kleiner DE,Bonkovsky HL, Amoxicillin-Clavulanate-Induced Liver Injury. Digestive diseases and sciences. 2016 Aug;
[PubMed PMID: 27003146]
[23]
Chalasani NP,Hayashi PH,Bonkovsky HL,Navarro VJ,Lee WM,Fontana RJ, ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. The American journal of gastroenterology. 2014 Jul;
[PubMed PMID: 24935270]
[24]
Hussaini SH,Farrington EA, Idiosyncratic drug-induced liver injury: an overview. Expert opinion on drug safety. 2007 Nov
[PubMed PMID: 17967156]
Level 3 (low-level) evidence
[25]
Giordano C,Rivas J,Zervos X, An Update on Treatment of Drug-Induced Liver Injury. Journal of clinical and translational hepatology. 2014 Jun
[PubMed PMID: 26356645]
[26]
Polson J,Lee WM, AASLD position paper: the management of acute liver failure. Hepatology (Baltimore, Md.). 2005 May
[PubMed PMID: 15841455]